Kaleido Biosciences Inc 's ROA from the fourth quarter of 2021 to the fourth quarter of 2020 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics

What is Kaleido Biosciences Inc 's ROA in the fourth quarter of 2021?
Kaleido Biosciences Inc recorded a cumulative net loss of $-90 million during 12 months ending in the fourth quarter of 2021, resulting in a negative return on assets (ROA) of -118.83%.

However, within the Healthcare sector 1101 other companies had a higher return on assets. While return on assets, the total ranking has deteriorated compared to the third quarter of 2021 from 4727 to 5732.

What is ROA?

Select the Comparisons :

None ▼

Select the Ratio:

Return on Assets ROA▼

None ▼

Return on Assets ROA▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Assets	(Dec 31 2021) IV. Quarter	(Sep 30 2021) III. Quarter	(Jun 30 2021) II. Quarter	(Mar 31 2021) I. Quarter	(Dec 31 2020) IV. Quarter
Y / Y Total Assets Change	-16.1 %	-0.28 %	-3.17 %	59.4 %	-28.54 %
Y / Y Net Income Change	-	-	-	-	-
Net Income (TTM) in million	-90	-90	-90	-85	-82
Return On Assets (TTM)	-118.83 %	-115.07 %	-115.06 %	-107.79 %	-117.64 %
KLDO's Total Ranking	# 5732	# 4727	# 4763	# 4661	# 5174
Total Assets (TTM) in million	48	71	82	103	57
Seq. Total Assets Change	-32.22 %	-13.81 %	-20.16 %	79.89 %	-19.44 %
Seq. Net Income Change	-	-	-	-	-

KLDO's 5 Years Annual ROA >> Back to KLDO Management Effectiveness >> Compare KLDO ROA to its Competitors

Return On Assets Company Ranking
Within:	No.
Industry	# 163
Sector	# 1102
Overall	# 5608

Return On Assets Statistics
High	Average	Low
-83.25 %	-105.1 %	-117.48 %
(Dec 31 2019)		(Dec 31 2021)

Financial Statements
Kaleido Biosciences Inc 's Assets	$ 48 million	KLDO's Balance sheet
Kaleido Biosciences Inc 's Income	$ -20 million	Quarterly KLDO's Income Statement
KLDO's Income by Division		See KLDO's Income by Division

Annual Return On Assets	(Dec 31 2021) FY 2021	(Dec 31 2020) FY 2020	(Dec 31 2019) FY 2019	FY	FY
Y / Y Total Assets Change	-16.1 %	-28.54 %	-	-	-
Total Assets in million	48	57	80	0	0
Y / Y Net Income Change	-	-	-	-	-
Net Income in million	-90	-82	-86	0	0
Annual Return On Assets	-188.19 %	-142.73 %	-107.89 %	-	-

KLDO's 5 Years Annual ROA >> Back to KLDO Management Effectiveness >> Compare KLDO ROA to its Competitors

More Return On Assets Ratios
KLDO's' Return on Assets at Yahoo Finance
Biotechnology & Pharmaceuticals Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
KLDO's Roa Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for KLDO's Competitors
Subscribers only: Roa for Kaleido Biosciences Inc 's Suppliers
Subscribers only: Return On Assets for KLDO's Customers

You may also want to know
KLDO's Roi	KLDO's Inventory Turnover Ratio	KLDO's Growth Rates	KLDO's Dividend Comparisons
	KLDO's Profitability Ratios	KLDO's Asset Turnover Ratio	KLDO's Dividend Growth
KLDO's Roe	KLDO's Valuation Ratios	KLDO's Financial Strength Ratios	KLDO's Dividend Payout Ratio

Companies with similar Return On Assets at Dec 31 2021, within Healthcare Sector

ROA

Date modified: 2026-09-08T15:10:34+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.